NCT06591780

Brief Summary

This study aims to collect data to improve gait function in individuals with Diabetic Peripheral Neuropathy (DPN). The primary goals are to evaluate:

  • Biomechanical mechanisms contributing to abnormal plantar pressure and propulsion during gait in individuals with DPN
  • Biofeedback-induced changes in plantar pressure, propulsion, and biomechanics during gait in individuals with DPN The participants will be required to complete
  • Questionnaires
  • Clinical examination
  • 3-Dimensional gait analysis on an instrumented treadmill
  • Visual and auditory biofeedback on the participant's propulsion and plantar pressure metrics provided by a projector screen during walking

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
25

participants targeted

Target at below P25 for not_applicable

Timeline
13mo left

Started Oct 2025

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress34%
Oct 2025Jun 2027

First Submitted

Initial submission to the registry

September 9, 2024

Completed
10 days until next milestone

First Posted

Study publicly available on registry

September 19, 2024

Completed
1.1 years until next milestone

Study Start

First participant enrolled

October 20, 2025

Completed
1.6 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 1, 2027

Expected
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

June 1, 2027

Last Updated

March 11, 2026

Status Verified

March 1, 2026

Enrollment Period

1.6 years

First QC Date

September 9, 2024

Last Update Submit

March 9, 2026

Conditions

Keywords

anterior ground reaction forcebiofeedback-induced changes in plantar pressurediabetic peripheral neuropathy

Outcome Measures

Primary Outcomes (2)

  • Biomechanical plantar pressure

    Plantar pressure is calculated in kilopascals (kPa) using a force sensor placed between the participant's foot and insole of their shoe. The peak plantar pressure in regions of interest (forefoot) will be calculated.

    Study Session 2 (occurs 24 hours up to 2 weeks after Session 2)

  • Biomechanical Propulsion

    Propulsion is calculated as the maximum anteriorly directed ground reaction force during the stance phase of gait using the instrumented (force plate) treadmill.

    Study Session 2 (occurs 24 hours up to 2 weeks after Session 2)

Secondary Outcomes (3)

  • Changes induced by biofeedback in plantar pressure

    Study Session 3 (occurs 24 hours up to 2 weeks after Session 3)

  • Changes induced by biofeedback in propulsion

    Study Session 3 (occurs 24 hours up to 2 weeks after Session 3)

  • Changes induced by biofeedback in biomechanics during gait

    Study Session 3 (occurs 24 hours up to 2 weeks after Session 3)

Study Arms (1)

Real-Time Biofeedback Walking Trials

EXPERIMENTAL

Real-time biofeedback of propulsion and plantar pressure to measure the immediate effects of biofeedback on walking function and gait mechanics. Permuted block randomization (blocks of 4) will be used to allocate the order of the biofeedback stimulus (plantar pressure-intervention A or propulsion-intervention B). Participants will receive both interventions in session 3, but the order will be randomized.

Other: Clinical EvaluationOther: Plantar Pressure Biofeedback Gait TrainingOther: Propulsion Biofeedback Gait Training

Interventions

A clinical evaluation occurs at the first study session. The clinical evaluation assesses walking function and mobility, lower extremity, sensation, health-related quality of life (HRQoL) and foot function. Session 2 will be a dynamometer-based evaluation of passive ankle stiffness and a 3-dimensional gait analysis to evaluate baseline biomechanics. During Session 3, real-time biofeedback conditions will be used to measure the immediate effects on walking function.

Real-Time Biofeedback Walking Trials

Participants will complete a 3-dimensional gait evaluation prior to training, after a 6-minute control bout without biofeedback, and following three 6-minute biofeedback training bouts (total 18-minutes). Individualized biofeedback targets will be calculated from each participant's immediate biofeedback session to best minimize plantar pressure whilst maintaining or enhancing propulsion. Audio-visual biofeedback is provided using a screen placed in front of the treadmill and a speaker. For plantar pressure biofeedback, a visual display of a foot with a colored heat map represents the current plantar pressure, in addition to bar graphs representing real-time movement of plantar pressure in specific areas of the foot. A target is provided using the heat map colors of red and target line on the bar graph. Participants are informed that the target is a measurement of the pressure under their foot, and their goal is to decrease pressure to achieve their target

Also known as: Intervention A
Real-Time Biofeedback Walking Trials

Participants will complete a 3-dimensional gait evaluation prior to training, after a 6-minute control bout without biofeedback, and following three 6-minute biofeedback training bouts (total 18-minutes). Individualized biofeedback targets will be calculated from each participant\'s immediate biofeedback session to best minimize plantar pressure whilst maintaining or enhancing propulsion. Audio-visual biofeedback is provided using a screen placed in front of the treadmill and a speaker. For propulsion biofeedback, a visual display with a marker represents the current propulsion (peak AGRF) and a target provided to modulate propulsion. Participants are informed that the marker is a measurement of how hard they are pushing the ground backward, and their goal is to push-off more to achieve their target.

Also known as: Intervention B
Real-Time Biofeedback Walking Trials

Eligibility Criteria

Age45 Years - 90 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Able to walk 10-meters independently without an assistive device
  • Sufficient cardiovascular and musculoskeletal health to walk on a treadmill for 6 minutes at a self-selected speed
  • Diagnosis of diabetes mellitus
  • Diagnosis of diabetic peripheral neuropathy by a physician
  • Foot examination within the past 6 months documenting ambulatory status
  • Physician clearance

You may not qualify if:

  • History of amputation
  • Active ulceration
  • Medial column deformity
  • Severe cognitive impairment (MoCA \< 10)
  • Severe visual impairment
  • History of Charcot osteoarthropathy
  • History of posterior muscle group lengthening
  • History of lower extremity joint replacement
  • History of lower extremity and/or foot surgery affecting walking mechanics
  • Orthopaedic problems of the lower limbs or spine due to other medical conditions (not diabetes or DPN) that limit walking or cause pain during walking
  • Improper footwear for walking and community ambulation
  • Cardiovascular or medical condition affecting ability to walk safely
  • History of unexplained dizziness or fainting in the past 2 months
  • Allergy to adhesive tape or rubbing alcohol

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Florida Institute for Human and Machine Cognition

Pensacola, Florida, 32502, United States

RECRUITING

MeSH Terms

Conditions

Diabetes Mellitus

Condition Hierarchy (Ancestors)

Glucose Metabolism DisordersMetabolic DiseasesNutritional and Metabolic DiseasesEndocrine System Diseases

Study Officials

  • Nicole K Rendos, PhD

    Florida Institute for Human and Machine Cognition

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Nicole K Rendos, PhD

CONTACT

Craig Tuggle

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
BASIC SCIENCE
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Research Scientist

Study Record Dates

First Submitted

September 9, 2024

First Posted

September 19, 2024

Study Start

October 20, 2025

Primary Completion (Estimated)

June 1, 2027

Study Completion (Estimated)

June 1, 2027

Last Updated

March 11, 2026

Record last verified: 2026-03

Data Sharing

IPD Sharing
Will share

Data on demographics, medical history, clinical evaluation, questionnaires, walking biomechanics, and plantar pressure data will be collected from individuals (N = 25) with diabetic peripheral neuropathy. Subject-level de-identified data will be preserved and shared in raw and pre-processed forms in ".csv" and ".xlsx" format. Biomechanics data will be processed and saved in ".c3d" formatted files as per standard practice in the field of biomechanics.

Shared Documents
STUDY PROTOCOL, SAP, ICF
Time Frame
All data will be deposited 6 months following the completion of the study. At a minimum, the data will be made available for 3 years after the completion of the study.
Access Criteria
Raw and pre-processed data will be archived through the National Institute of Child Health and Human Development (NICHD) Data and Specimen Hub (DASH). Processed biomechanics data will be archived through SimTK. The archived data will be assigned digital object identifiers (DOI). Both NICHD DASH and SimTK are made available through web-accessible repositories at no cost to users.

Locations